insight into new technologies
Evonik also obtains access to innovative technologies and new business options through its corporate venture capital activities.
We invest specifically in specialized technology
funds and start-ups of strategic relevance to Evonik. In this way, we gain insights into innovative developments at a very early stage. We have made more than 24 investments since 2012.
Strategic focus on the following Evonik competencies
NUMAFERM, a biotechnology company, is working on more efficient production of peptides.
Peptides and their applications are of enormous interest for our Specialty Additives and Health & Care growth engines.
Digital Growth Fund I
This fund provides capital for fast-growing young IndustrialTech and FinTech companies with proven and successful B2B business models.
Our investment in Digital Growth Fund I is a strong partnership that strengthens Evonik in an important field of the future: digitalization.
Evonik Venture Capital GmbH
Evonik Venture Capital GmbH, the venture capital group of Evonik Industries AG invests in highly promising start-ups with break-through technologies and leading.more